ClinicalTrials.gov - NCT07118891: ABCL635 Vasomotor Symptoms Study

Tier 1: Established: peer-reviewed research or government health authority
Publisher: U.S. National Library of Medicine / ClinicalTrials.gov · Published: January 1, 2025 · Accessed: August 14, 2026

Visit the source ↗

Claims this source supports

• NCT07118891 is a Phase 1/2 clinical trial evaluating ABCL635 for vasomotor symptoms of menopause.
• As of August 2026 the trial's overall status is 'active, not recruiting' with 136 participants enrolled.
• The trial evaluates safety, tolerability, pharmacokinetics, pharmacodynamics, and the frequency and severity of vasomotor symptoms.